Silo Pharma (SILO) Accumulated Expenses (2012 - 2024)

Silo Pharma has reported Accumulated Expenses for 5 years, with the latest figure at $63820.0 in Q1 2024.

• Quarterly Accumulated Expenses rose 216.98% year-over-year to $63820.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $63820.0 (up 216.98% YoY) and the FY2023 annual result came in at $5891.0, down 70.74% from the prior year.
• Accumulated Expenses climbed to $63820.0 in Q1 2024 per SILO's latest filing, from $5891.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $92095.0 in Q3 2023 and troughed at $5891.0 in Q4 2023.
• A 3-year average of $40414.8 and a median of $20134.0 in 2022 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2024: Accumulated Expenses tumbled 70.74% in 2023, then surged 216.98% in 2024.
• Over 3 years, Accumulated Expenses stood at $20134.0 in 2022, then sank by 70.74% to $5891.0 in 2023, then jumped by 983.35% to $63820.0 in 2024.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $63820.0, $5891.0, and $92095.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.